Inhalerx Ltd (IRX) — Cash Flow-to-Debt Ratio
Inhalerx Ltd (IRX) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2025, meaning its operating cash flow of AU$38.91K could theoretically repay 0% of its total liabilities (AU$2.31 Million) in one year. See IRX free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Inhalerx Ltd Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for Inhalerx Ltd across 9 annual periods. Also explore Inhalerx Ltd (IRX) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Inhalerx Ltd (2016–2024)
Year-by-year debt coverage analysis for Inhalerx Ltd. For market capitalisation and broader financial context, see Inhalerx Ltd (IRX) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.47x | AU$-368.77K | AU$776.37K | ▲ +77.9% |
| 2023 | -2.15x | AU$-1.96 Million | AU$911.41K | ▲ +58.6% |
| 2022 | -5.20x | AU$-1.85 Million | AU$355.32K | ▼ -14.6% |
| 2021 | -4.53x | AU$-1.15 Million | AU$253.34K | ▼ -142.2% |
| 2020 | -1.87x | AU$-1.09 Million | AU$580.10K | ▲ +71.6% |
| 2019 | -6.58x | AU$-1.87 Million | AU$283.63K | ▼ -30.1% |
| 2018 | -5.06x | AU$-2.06 Million | AU$408.33K | ▼ -14.4% |
| 2017 | -4.42x | AU$-2.56 Million | AU$579.51K | ▼ -2306.3% |
| 2016 | -0.18x | AU$-229.03K | AU$1.25 Million | — |